These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 23569328)

  • 21. Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses.
    Leen A; Meij P; Redchenko I; Middeldorp J; Bloemena E; Rickinson A; Blake N
    J Virol; 2001 Sep; 75(18):8649-59. PubMed ID: 11507210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.
    Gurer C; Strowig T; Brilot F; Pack M; Trumpfheller C; Arrey F; Park CG; Steinman RM; Münz C
    Blood; 2008 Aug; 112(4):1231-9. PubMed ID: 18519810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linked immunospot assay.
    Calarota SA; Chiesa A; Zelini P; Comolli G; Minoli L; Baldanti F
    Immunology; 2013 Aug; 139(4):533-44. PubMed ID: 23560877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection.
    Precopio ML; Sullivan JL; Willard C; Somasundaran M; Luzuriaga K
    J Immunol; 2003 Mar; 170(5):2590-8. PubMed ID: 12594286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
    Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
    J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients.
    Lin X; Gudgeon NH; Hui EP; Jia H; Qun X; Taylor GS; Barnardo MC; Lin CK; Rickinson AB; Chan AT
    Cancer Immunol Immunother; 2008 Jul; 57(7):963-75. PubMed ID: 18094968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy.
    Adhikary D; Behrends U; Boerschmann H; Pfünder A; Burdach S; Moosmann A; Witter K; Bornkamm GW; Mautner J
    PLoS One; 2007 Jul; 2(7):e583. PubMed ID: 17611619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
    Wang Z; Kennedy PG; Dupree C; Wang M; Lee C; Pointon T; Langford TD; Graner MW; Yu X
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):567-580. PubMed ID: 32808238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection.
    Hislop AD; Annels NE; Gudgeon NH; Leese AM; Rickinson AB
    J Exp Med; 2002 Apr; 195(7):893-905. PubMed ID: 11927633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines.
    Long HM; Haigh TA; Gudgeon NH; Leen AM; Tsang CW; Brooks J; Landais E; Houssaint E; Lee SP; Rickinson AB; Taylor GS
    J Virol; 2005 Apr; 79(8):4896-907. PubMed ID: 15795275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.
    Steigerwald-Mullen P; Kurilla MG; Braciale TJ
    J Virol; 2000 Aug; 74(15):6748-59. PubMed ID: 10888613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.
    Catalina MD; Sullivan JL; Bak KR; Luzuriaga K
    J Immunol; 2001 Oct; 167(8):4450-7. PubMed ID: 11591771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein.
    Szigeti R; Kallin B; Dillner J; Henle G; Henle W; Lerner RA; Rymo L; Timar L; Klein G
    Clin Immunol Immunopathol; 1989 Jun; 51(3):396-405. PubMed ID: 2470542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.
    Kalra M; Gerdemann U; Luu JD; Ngo MC; Leen AM; Louis CU; Rooney CM; Gottschalk S
    Cytotherapy; 2019 Feb; 21(2):212-223. PubMed ID: 30396848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr virus infection with TCR-like antibodies.
    Sim AC; Too CT; Oo MZ; Lai J; Eio MY; Song Z; Srinivasan N; Tan DA; Pang SW; Gan SU; Lee KO; Loh TK; Chen J; Chan SH; MacAry PA
    Sci Rep; 2013 Nov; 3():3232. PubMed ID: 24240815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.
    Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows SR; Burrows JM; Moss DJ; Argaet VP; Misko IS
    J Exp Med; 1996 Nov; 184(5):1815-24. PubMed ID: 8920869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
    Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
    mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.
    White CA; Cross SM; Kurilla MG; Kerr BM; Schmidt C; Misko IS; Khanna R; Moss DJ
    Virology; 1996 May; 219(2):489-92. PubMed ID: 8638417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.
    Piriou E; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
    Blood; 2005 Nov; 106(9):3166-74. PubMed ID: 16014568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.
    Heller KN; Upshaw J; Seyoum B; Zebroski H; Münz C
    Blood; 2007 Feb; 109(3):1138-46. PubMed ID: 16985171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.